Microscopic colitis: A review of etiology, treatment and refractory disease

World Journal of Gastroenterology

Volumn 21, Issue 29, 2015, Pages 8903-8911

  Park, Tina ^a   Cave, David ^a   Marshall, Christopher ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Chronic diarrhea; Collagenous colitis; Etiology of microscopic colitis; Lymphocytic colitis; Microscopic colitis; Refractory microscopic colitis; Steroid dependent microscopic colitis

Indexed keywords

AMINOSALICYLIC ACID; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISMUTH; COLESTYRAMINE; CORTICOSTEROID; DIPHENOXYLATE; IMMUNOMODULATING AGENT; LOPERAMIDE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR INHIBITOR; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CELIAC DISEASE; COLON RESECTION; DISEASE ASSOCIATION; DRUG EXPOSURE; HUMAN; ILEOSTOMY; LIFESTYLE MODIFICATION; MICROSCOPIC COLITIS; MULTICENTER STUDY (TOPIC); NONHUMAN; POLYARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; THYROID DISEASE; ADVERSE EFFECTS; COLITIS, MICROSCOPIC; RECURRENT DISEASE; REMISSION; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; COLITIS, MICROSCOPIC; HUMANS; ILEOSTOMY; IMMUNOSUPPRESSIVE AGENTS; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84939817931     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i29.8804     Document Type: Article

References (32)

1. Pardi DS, Loftus EV, Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, Harmsen WS, Zinsmeister AR, Melton LJ, Sandborn WJ. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504-508 [PMID: 17135309 DOI: 10.1136/gut.2006.105890]
2. Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A. Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology 2015; 66: 613-626 [PMID: 25381724 DOI: 10.1111/his.12592]
3. Madisch A, Hellmig S, Schreiber S, Bethke B, Stolte M, Miehlke S. Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis. Inflamm Bowel Dis 2011; 17: 2295-2298 [PMID: 21305678 DOI: 10.1002/ibd.21640]
4. Fernández-Bañares F, de Sousa MR, Salas A, Beltrán B, Piqueras M, Iglesias E, Gisbert JP, Lobo B, Puig-Diví V, García-Planella E, Ordás I, Andreu M, Calvo M, Montoro M, Esteve M, Viver JM. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis 2013; 19: 411-417 [PMID: 23344243 DOI: 10.1002/ibd.23009]
5. Vigren L, Sjöberg K, Benoni C, Tysk C, Bohr J, Kilander A, Larsson L, Ström M, Hjortswang H. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol 2011; 46: 1334-1339 [PMID: 21854096 DOI: 10.3109/00365521.2011.610005]
6. Münch A, Langner C. Microscopic colitis: clinical and pathologic perspectives. Clin Gastroenterol Hepatol 2015; 13: 228-236 [PMID: 24407107 DOI: 10.1016/j.cgh.2013.12.026]
7. Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol 2015; 110: 749-759 [PMID: 25916221 DOI: 10.1038/ajg.2015.119]
8. Barmeyer C, Erko I, Fromm A, Bojarski C, Allers K, Moos V, Zeitz M, Fromm M, Schulzke JD. Ion transport and barrier function are disturbed in microscopic colitis. Ann N Y Acad Sci 2012; 1258: 143-148 [PMID: 22731727 DOI: 10.1111/j.1749-6632.2012.06631.x]
9. Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 2007; 60: 382-387 [PMID: 16775121 DOI: 10.1136/ jcp.2005.036376]
10. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-851 [PMID: 9038667 DOI: 10.1136/gut.39.6.846]
11. Peterson TC, Cleary CE, Shaw AM, Malatjalian DA, Veldhuyzen van Zanten SJ. Therapeutic role for bismuth compounds in TNBSinduced colitis in the rat. Dig Dis Sci 2000; 45: 466-473 [PMID: 10749319]
12. Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 1998; 114: 29-36 [PMID: 9428215 DOI: 10.1016/S0016-5085(98)70629-8]
13. Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000; 46: 170-175 [PMID: 10644309 DOI: 10.1136/ gut.46.2.170]
14. Calabrese C, Fabbri A, Areni A, Zahlane D, Scialpi C, Di Febo G. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol 2007; 22: 809-814 [PMID: 17565633 DOI: 10.1111/ j.1440-1746.2006.04511.x]
15. Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014; 146: 1222-1230.e1-2 [PMID: 24440672 DOI: 10.1053/j.gastro.2014.01.019]
16. Münch A, Bohr J, Miehlke S, Benoni C, Olesen M, Ost A, Strandberg L, Hellström PM, Hertervig E, Armerding P, Stehlik J, Lindberg G, Björk J, Lapidus A, Löfberg R, Bonderup O, Avnström S, Rössle M, Dilger K, Mueller R, Greinwald R, Tysk C, Ström M; on behalf of the BUC-63 investigators. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 2014; Epub ahead of print [PMID: 25425655 DOI: 10.1136/ gutjnl-2014-308363]
17. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104: 235-241; quiz 234, 242 [PMID: 19098875 DOI: 10.1038/ ajg.2008.16]
18. Gentile NM, Abdalla AA, Khanna S, Smyrk TC, Tremaine WJ, Faubion WA, Kammer PP, Sandborn WJ, Loftus EV, Pardi DS. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol 2013; 108: 256-259 [PMID: 23295275 DOI: 10.1038/ajg.2012.416]
19. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009; 58: 68-72 [PMID: 18669576 DOI: 10.1136/ gut.2008.156513]
20. Miehlke S, Hansen JB, Madisch A, Schwarz F, Kuhlisch E, Morgner A, Teglbjaerg PS, Vieth M, Aust D, Bonderup OK. Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy. Inflamm Bowel Dis 2013; 19: 2763-2767 [PMID: 24216688 DOI: 10.1097/01. MIB.0000438135.88681.98]
21. Münch A, Bohr J, Vigren L, Tysk C, Ström M. Lack of effect of methotrexate in budesonide-refractory collagenous colitis. Clin Exp Gastroenterol 2013; 6: 149-152 [PMID: 24039441 DOI: 10.2147/CEG.S48201]
22. Münch A, Fernandez-Banares F, Munck LK. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis. Aliment Pharmacol Ther 2013; 37: 795-798 [PMID: 23432370 DOI: 10.1111/apt.12261]
23. Aram G, Bayless TM, Chen ZM, Montgomery EA, Donowitz M, Giardiello FM. Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy. Clin Gastroenterol Hepatol 2010; 8: 391-394 [PMID: 20036760 DOI: 10.1016/ j.cgh.2009.12.010]
24. Pola S, Fahmy M, Evans E, Tipps A, Sandborn WJ. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis. Am J Gastroenterol 2013; 108: 857-858 [PMID:
25. DOI: 10.1038/ajg.2013.43]
26. Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011; 5: 612-618 [PMID: 22115383 DOI: 10.1016/j.crohns.2011.05.001]
27. Münch A, Ignatova S, Ström M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol 2012; 47: 59-63 [PMID: 22149977 DOI: 10.3109/00365521.2011. 639079]
28. Williams RA, Gelfand DV. Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis. Am J Gastroenterol 2000; 95: 2147 [PMID: 10950095 DOI: 10.1111/j.1572-0241.2000.02225.x]
29. Münch A, Söderholm JD, Wallon C, Ost A, Olaison G, Ström M. Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy. Gut 2005; 54: 1126-1128 [PMID: 16009686 DOI: 10.1136/ gut.2004.058750]
30. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109: 449-455 [PMID: 7615194 DOI: 10.1016/0016-5085(95)90332-1]
31. Pardi DS, Loftus EV, Tremaine WJ, Sandborn WJ. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001; 120: 1483-1484 [PMID:11313319 DOI: 10.1053/gast.2001.23976]
32. Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, Vogel G, Andersen M, Meier E, Baretton G, Stolte M. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008; 135: 1510-1516 [PMID: 18926826 DOI: 10.1053/j.gastro.2008.07.081]